Recombinant proteins sit at the heart of how we probe and control biology, and Recombinant Human 4-1BBL is the one that reliably tunes T cells when it counts. It supports work that spans basic immunology, oncology models, and autoimmune studies, and the difference between average and high-quality material shows up plainly at the bench. Here we focus on what 4-1BBL does, where it is applied, how careful expression, purification, and quality control preserve its activity, why our platform at East Mab Bio delivers consistent lots, and where 4-1BBL-based therapies are heading.
4-1BBL, also known as CD137L, is a key protein belonging to the TNF superfamily. It interacts with its receptor, 4-1BB (CD137), which is primarily expressed on activated T cells. This interaction delivers a powerful co-stimulatory signal required for robust T-cell responses. The binding of 4-1BBL to 4-1BB initiates downstream signaling pathways. These pathways enhance T-cell proliferation, improve cell survival, and augment effector functions. This mechanism is vital for both CD4+ helper T cells and CD8+ cytotoxic T lymphocytes. Consequently, 4-1BBL plays a significant role in shaping effective adaptive immunity.

The fundamental biology of 4-1BBL (CD137L) positions it as a key member of the TNF superfamily. Its receptor, 4-1BB (CD137), resides on activated T cells. When 4-1BBL binds to 4-1BB, it provides the co-stimulatory signals needed. These signals enhance T-cell proliferation, survival, and effector functions. This interaction is important in both CD4+ and CD8+ T-cell responses.
Recombinant Human 4-1BBL is a versatile tool with broad applications across immunology and oncology. Its ability to modulate T-cell activity makes it invaluable for various research avenues. We utilize it to explore complex immune mechanisms and develop new therapeutic strategies.
Researchers extensively use 4-1BBL in developing novel cancer immunotherapies. This includes enhancing CAR-T cell therapy, informing checkpoint blockade strategies, and improving vaccine development. Recombinant 4-1BBL helps study anti-tumor immunity in both in vitro and in vivo models. It provides the necessary co-stimulatory signals to boost T-cell activity against cancer cells. This makes it a critical component for optimizing adoptive cell therapies and understanding the tumor microenvironment.
Recombinant 4-1BBL also helps understand and modulate autoimmune responses. It is applied in studying inflammatory pathways and identifying potential therapeutic targets. This includes conditions like rheumatoid arthritis or multiple sclerosis. By using 4-1BBL, researchers can investigate how to fine-tune immune responses to prevent self-tissue damage.
The integrity and biological activity of recombinant proteins determine whether results hold up. Producing high-quality Recombinant Human 4-1BBL requires meticulous attention to detail at every stage. We adhere to stringent protocols to ensure our products meet the highest standards.
Producing high-quality Recombinant Human 4-1BBL involves several critical steps. First, selecting the appropriate expression system matters. Mammalian cells, such as CHO cells, are often preferred for proper glycosylation and folding of human proteins. Next, purification techniques, like affinity chromatography, isolate the target protein from cellular contaminants. Maintaining protein integrity and stability throughout the process is vital. This ensures the recombinant protein retains its native conformation and biological activity.
We perform core quality control assays for recombinant 4-1BBL. These assays confirm its suitability for research and therapeutic applications.
| Quality Parameter | Assay Method | Acceptance Criteria | Importance |
|---|---|---|---|
| Purity | SDS-PAGE, HPLC | ≥95% | Ensures specific protein activity and prevents interference from impurities. |
| Bioactivity | T-cell proliferation assay, Cytokine production assay | ED₅₀ ≤ [Specific Value] | Confirms the protein’s functional capacity to induce desired biological effects. |
| Endotoxin Levels | LAL assay | ≤10 EU/mg | Minimizes inflammatory responses in cell culture and in vivo studies. |
| Molecular Weight | SDS-PAGE | ~18-20 kDa (monomer) | Confirms correct protein size and integrity. |
| Stability | Accelerated stability testing | Retains activity for specified duration | Guarantees product shelf-life and consistent performance over time. |
Bioactivity assays, such as T-cell proliferation assays or cytokine production measurements, confirm the protein’s functional capacity. Purity assessment through SDS-PAGE and HPLC ensures the absence of contaminants. Endotoxin testing via LAL assay is vital to prevent non-specific immune activation. These rigorous controls ensure reliable and reproducible research outcomes.
Jiangsu East-Mab Biomedical Technology Co., Ltd, established in 2016, is a leading biotechnology company. We focus on providing high-quality recombinant protein raw materials globally. Our commitment to excellence drives our production of Recombinant Human 4-1BBL.
EastMabBio has invested over $30 million in a world-class platform. This platform supports recombinant protein research, validation, and production. We provide superior recombinant protein raw materials, including Recombinant Human 4-1BBL. Our advanced technology and expertise ensure high-quality products for global research and development. We support advancements in IVD, cell culture media, cell therapy, organoids, cosmetics, and cultivated meat.
Sourcing Recombinant Human 4-1BBL from EastMabBio offers distinct advantages. We guarantee high purity, confirmed by rigorous analytical methods. Our products demonstrate high bioactivity, ensuring effective experimental results. We maintain low endotoxin levels, critical for sensitive cell culture and in vivo applications. Our processes ensure consistent batch-to-batch quality, providing reliability for long-term projects. We also provide dedicated technical support to assist our clients. These benefits directly address the need for dependable recombinant proteins in complex research and development.
The therapeutic potential of 4-1BBL extends beyond research applications. Its role in immune co-stimulation positions it as a promising target for medical interventions. We anticipate significant advancements in this area.
Ongoing clinical trials and preclinical studies explore 4-1BBL-based therapies. These include soluble 4-1BBL, 4-1BB agonists, and bispecific antibodies. These emerging therapies hold significant promise for treating various diseases. Their impact is especially strong in oncology and chronic infections. Researchers are developing these agents to precisely modulate immune responses. This will lead to more effective and targeted treatments.
Recombinant Human 4-1BBL (4-1BB Ligand or CD137L) is a protein that binds to the 4-1BB receptor on activated T cells. Its primary function is to provide a needed co-stimulatory signal that enhances T-cell proliferation, survival, and effector functions, playing a vital role in immune responses, particularly anti-tumor immunity.
High-quality Recombinant Human 4-1BBL is paramount because its bioactivity, purity, and endotoxin levels directly impact the reliability and reproducibility of experimental results and the safety of potential therapeutic applications. Inconsistent quality can lead to misleading data or adverse effects in preclinical studies.
Recombinant Human 4-1BBL is widely used in immunology and oncology research to study T-cell activation, enhance CAR-T cell therapies, investigate immune checkpoint modulation, and develop novel cancer immunotherapies. It also plays a role in understanding and modulating autoimmune diseases and inflammatory responses.
EastMabBio ensures the highest quality of Recombinant Human 4-1BBL through a world-class production platform utilizing advanced expression systems and rigorous purification protocols. We conduct extensive quality control, including bioactivity assays, SDS-PAGE, HPLC for purity, and LAL assays for endotoxin levels, guaranteeing consistent, reliable, and high-performance products.
Advance your research and therapeutic development with high-quality Recombinant Human 4-1BBL from East Mab Bio. Contact us today to learn more about our premium recombinant protein products and how we can support your scientific endeavors. Visit our product page or speak with our experts at +86-400-998-0106 or product@eastmab.com.
News
Platform Information Submission-Privacy Agreement
· Privacy Policy
No content yet
Platform Information Statement-Laws and Regulations
· Laws and regulations
Trademark registration of Jiangsu Dongkang Biomedical Technology Co., Ltd.
East Mab
East Mab Bio
东抗生物